Ingevity Corp
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sell… Read more
Ingevity Corp (NGVT) - Net Assets
Latest net assets as of September 2025: $138.10 Million USD
Based on the latest financial reports, Ingevity Corp (NGVT) has net assets worth $138.10 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.83 Billion) and total liabilities ($1.70 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $138.10 Million |
| % of Total Assets | 7.53% |
| Annual Growth Rate | -4.61% |
| 5-Year Change | -69.84% |
| 10-Year Change | -62.61% |
| Growth Volatility | 48.66 |
Ingevity Corp - Net Assets Trend (2013–2024)
This chart illustrates how Ingevity Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ingevity Corp (2013–2024)
The table below shows the annual net assets of Ingevity Corp from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $195.20 Million | -69.08% |
| 2023-12-31 | $631.40 Million | -9.58% |
| 2022-12-31 | $698.30 Million | +3.64% |
| 2021-12-31 | $673.80 Million | +4.09% |
| 2020-12-31 | $647.30 Million | +21.95% |
| 2019-12-31 | $530.80 Million | +56.30% |
| 2018-12-31 | $339.60 Million | +22.29% |
| 2017-12-31 | $277.70 Million | +106.32% |
| 2016-12-31 | $134.60 Million | -74.21% |
| 2015-12-31 | $522.00 Million | +24.29% |
| 2014-12-31 | $420.00 Million | +28.05% |
| 2013-12-31 | $328.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ingevity Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 57200000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $572.00 Million | 293.03% |
| Common Stock | $400.00K | 0.20% |
| Other Comprehensive Income | $-41.40 Million | -21.21% |
| Total Equity | $195.20 Million | 100.00% |
Ingevity Corp Competitors by Market Cap
The table below lists competitors of Ingevity Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Teleperformance PK
PINK:TLPFY
|
$2.43 Billion |
|
PSKRY
PINK:PSKRY
|
$2.43 Billion |
|
Quilter plc
PINK:QUILF
|
$2.43 Billion |
|
Henan Pinggao Electric Co Ltd
SHG:600312
|
$2.43 Billion |
|
Chongyi Zhangyuan Tungsten Co Ltd
SHE:002378
|
$2.43 Billion |
|
Loar Holdings Inc.
NYSE:LOAR
|
$2.42 Billion |
|
Independent Bank Group Inc
NASDAQ:IBTX
|
$2.42 Billion |
|
Chunghwa Precision Test Tech Co Ltd
TWO:6510
|
$2.42 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ingevity Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 631,400,000 to 195,200,000, a change of -436,200,000 (-69.1%).
- Net loss of 430,300,000 reduced equity.
- Share repurchases of 3,100,000 reduced equity.
- Other comprehensive income decreased equity by 14,700,000.
- Other factors increased equity by 11,900,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-430.30 Million | -220.44% |
| Share Repurchases | $3.10 Million | -1.59% |
| Other Comprehensive Income | $-14.70 Million | -7.53% |
| Other Changes | $11.90 Million | +6.1% |
| Total Change | $- | -69.08% |
Book Value vs Market Value Analysis
This analysis compares Ingevity Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 12.63x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 8.76x to 12.63x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $7.75 | $67.86 | x |
| 2014-12-31 | $9.91 | $67.86 | x |
| 2015-12-31 | $12.29 | $67.86 | x |
| 2016-12-31 | $3.18 | $67.86 | x |
| 2017-12-31 | $6.53 | $67.86 | x |
| 2018-12-31 | $7.97 | $67.86 | x |
| 2019-12-31 | $12.58 | $67.86 | x |
| 2020-12-31 | $15.58 | $67.86 | x |
| 2021-12-31 | $16.82 | $67.86 | x |
| 2022-12-31 | $18.15 | $67.86 | x |
| 2023-12-31 | $17.30 | $67.86 | x |
| 2024-12-31 | $5.37 | $67.86 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ingevity Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -220.44%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -30.60%
- • Asset Turnover: 0.70x
- • Equity Multiplier: 10.36x
- Recent ROE (-220.44%) is below the historical average (7.79%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 36.50% | 12.14% | 1.65x | 1.82x | $86.40 Million |
| 2014 | 30.94% | 12.39% | 1.45x | 1.72x | $87.30 Million |
| 2015 | 15.47% | 8.26% | 1.24x | 1.51x | $28.30 Million |
| 2016 | 26.15% | 3.88% | 1.09x | 6.19x | $21.74 Million |
| 2017 | 45.48% | 12.99% | 1.05x | 3.35x | $98.53 Million |
| 2018 | 49.79% | 14.92% | 0.86x | 3.87x | $135.14 Million |
| 2019 | 34.61% | 14.21% | 0.60x | 4.04x | $130.62 Million |
| 2020 | 28.02% | 14.92% | 0.52x | 3.61x | $116.67 Million |
| 2021 | 17.53% | 8.49% | 0.56x | 3.66x | $50.72 Million |
| 2022 | 30.30% | 12.68% | 0.61x | 3.92x | $141.77 Million |
| 2023 | -0.86% | -0.32% | 0.65x | 4.15x | $-68.54 Million |
| 2024 | -220.44% | -30.60% | 0.70x | 10.36x | $-449.82 Million |
Industry Comparison
This section compares Ingevity Corp's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $7,181,833,981
- Average return on equity (ROE) among peers: 7.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ingevity Corp (NGVT) | $138.10 Million | 36.50% | 12.28x | $2.43 Billion |
| AirBoss of America Corp (ABSSF) | $197.00 Million | -16.19% | 1.24x | $57.06 Million |
| Asia Carbon Industries Inc (ACRB) | $19.13 Million | 17.11% | 0.33x | $0.98 |
| Aimia Inc (AIMFF) | $1.29 Billion | -4.63% | 2.83x | $103.68 Million |
| L'Air Liquide S.A (AIQUF) | $11.83 Billion | 14.08% | 1.26x | $107.70 Billion |
| Akzo Nobel N.V (AKZOF) | $7.58 Billion | 14.03% | 1.29x | $9.73 Billion |
| Albemarle Corp (ALB) | $545.00 Million | 9.41% | 1.09x | $19.53 Billion |
| ALPEK S.A.B. de C.V (ALPKF) | $49.59 Billion | 15.64% | 1.50x | $214.40 Million |
| Altech Batteries Limited (ALTHF) | $97.54 Million | -5.87% | 0.01x | $27.89 Million |
| Arcadium Lithium plc (ALTM) | $333.00 Million | 14.14% | 0.12x | $6.26 Billion |
| Alto Ingredients Inc (ALTO) | $345.21 Million | 13.35% | 0.40x | $212.84 Million |